Jason R. Kelly, See remarks at Ginkgo Bioworks Holdings, Inc. (DNA), sold 400,000 shares at $1.34 ($595K) on 2023-12-13, disclosed to the SEC on 2023-12-15.
Scheduled sale ($595k) by See remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.34 | 99,020 | $133K | 22.3% |
| 2 | $1.34 | 99,020 | $133K | 22.3% |
| 3 | $1.63 | 100,980 | $165K | 27.7% |
| 4 | $1.63 | 100,980 | $165K | 27.7% |
| Total | $1.49 avg | 400,000 | $595K | 100% |
| Filing → |
| DNA | SELL | 2023-12-22 | $353K | — | Filing → |
| DNA | SELL | 2023-12-08 | $263K | — | Filing → |
| DNA | SELL | 2023-12-01 | $280K | — | Filing → |